Skip to content

To Explore the efficacy of drugs which increase the gastrointestinal motility in Diabetic Gastroparesis.

Efficacy of Pro-Kinetic Agents in Type 2 Diabetes Mellitus Patients with Gastric Autonomic Neuropathy using lactulose hydrogen breath testing

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/08/027264
Enrollment
100
Registered
2020-08-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications

Interventions

Intervention1: Levosulpiride 25mg once daily: Levosulpiride 25mg once daily for 4 weeks Intervention2: Cinitapride 1mg Thrice daily: Cinitapride 1mg Thrice daily for 4 weeks. Intervention3: Metoclopra

Sponsors

AIIMS RISHIKESH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All known/diagnosed TYPE 2 diabetic patient with delayed oro cecal transit time (OCTT) diagnosed on lactulose hydrogen breath test

Exclusion criteria

Exclusion criteria: All Type2 diabetic patient - -In whom gastro paresis is due to any drug intake like Narcotic pain medicines, Antidepressants Anticholinergics, amylin analogues. -Who underwent vagotomy / gastric surgery -Who have thyroid disorder (hypothyroidism) or parkinsonism -Pregnant females

Design outcomes

Primary

MeasureTime frame
To Explore the efficacy of prokinetic agents in Diabetic GastroparesisTimepoint: TO MEASURE THE CHANGE IN OCTT WITH LACTULOSE HYDROGEN BREATH TEST AFTER 1 MONTH OF DRUG.

Secondary

MeasureTime frame
To explore the relative advantage of one over the other prokinetic agents in Diabetic gastroparesis patientsTimepoint: TO MEASURE THE CHANGE IN OCTT WITH LACTULOSE HYDROGEN BREATH TEST AFTER 1 MONTH OF DRUG.

Countries

India

Contacts

Public ContactPRAKASH TENDULKAR

Department of general medicine, AIIMS Rishikesh

drkantr2006@gmail.com9625413607

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026